News & Updates
Showing Respirology articles
Showing
Show Multimedia Only

Subgroup findings boost dupilumab benefit for CRSwNP, comorbid asthma
18 Nov 2021
byAudrey Abella
In post hoc analyses of the phase III SINUS-24 and SINUS-52 trials, the monoclonal antibody dupilumab continued to render improvements for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP), as well as among those with comorbid asthma regardless of asthma characteristics.
18 Nov 2021

Dapagliflozin in COVID-19: Outcomes consistent regardless of kidney status
17 Nov 2021
byRoshini Claire Anthony
Secondary analysis of the DARE-19* trial presented at ASN Kidney Week 2021 has shown that the effect of dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19 is consistent regardless of kidney disease status.
17 Nov 2021
